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ABSTRACT 20 
Tissue homeostasis is critically dependent on the function of tissue-resident lymphocytes, 21 
including lipid-reactive invariant natural killer T (iNKT) cells. Yet, if and how the tissue 22 
environment shapes the antigen specificity of iNKT cells remains unknown. By analysing 23 
iNKT cells from lymphoid tissues of mice and humans we demonstrate that their T cell 24 
receptor (TCR) repertoire is highly diverse and is distinct for cells from various tissues 25 
resulting in differential lipid-antigen recognition. Within peripheral tissues iNKT cell recent 26 
thymic emigrants exhibit a different TCR repertoire than mature cells, suggesting that the 27 
iNKT population is shaped after arrival to the periphery. Consistent with this, iNKT cells from 28 
different organs show distinct basal activation, proliferation and clonal expansion. Moreover, 29 
the iNKT cell TCR repertoire changes following immunisation and is shaped by age and 30 
environmental changes. Thus, post-thymic modification of the TCR-repertoire underpins the 31 
distinct antigen specificity for iNKT cells in peripheral tissues  32 
 3 
INTRODUCTION 33 
Most anatomical compartments, including mucosal surfaces and solid organs, host large 34 
populations of tissue-resident lymphocytes which are uniquely placed to provide local 35 
networks for immune surveillance and defence against infection (Fan & Rudensky, 2016). 36 
Within the families of tissue-resident lymphocytes, invariant Natural Killer T (iNKT) cells 37 
constitute the body’s means to sense lipids, as antigens presented on CD1d (Salio et al., 38 
2014). Accordingly, iNKT cells recognise through their T cell receptors (TCR) self-lipids as 39 
well as lipids from pathogenic bacteria, commensals, fungi or pollens; consequently 40 
contributing to anti-microbial, antitumor and autoimmune responses (Salio et al., 2014). 41 
Since iNKT cell activation can prevent or promote immunopathology in diverse disease 42 
contexts, the strict control of peripheral iNKT cell homeostasis is vital to regulate local 43 
immunity. Beyond the common features shared by all iNKT cells (including their CD1-44 
restriction and innate-like properties), cells found in discrete tissues have distinct 45 
phenotypes and functions that critically modulate the outcome of immunity (Crosby & 46 
Kronenberg, 2018). This suggests that unique tissue-specific factors (including local lipid 47 
antigens, cytokines and/or hormones) may shape the population of iNKT cells resident in 48 
those tissues, ultimately regulating local immune responses. Consistent with this, alterations 49 
in CD1d-lipid presentation in the gut or the liver result in dysregulated homeostasis of local 50 
iNKT cells driving increased susceptibility to inflammation in these tissues (An et al., 2014; 51 
Zeissig et al., 2017). Nonetheless, how signals from the tissue environment shape the iNKT 52 
cell population to best fit their function in their tissues of residency remains unclear. 53 
 54 
iNKT cells have been traditionally defined by the expression of an invariant TCR α-chain 55 
(Vα14-Jα18 in mice or Vα24-Jα18 in humans) and their capacity to recognize the glycolipid 56 
antigen α-galactosylceramide (αGalCer) presented on CD1d. Despite this prototypical TCR 57 
repertoire gene usage, in recent years it has become apparent that there are variations 58 
within the iNKT cell repertoire that ultimately impact the antigen recognition capacity and 59 
consequently the functional outcomes during an immune response. In mice, although most 60 
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iNKT cells express the canonical Vα14-Jα18 TCR α-chain, they can use different Vβ chains 61 
and the combination of Vβ-, Jβ-, and CDR3β-encoded residues will ultimately determine the 62 
type of ligands that iNKT cells can bind (Cameron et al., 2015; Mallevaey et al., 2009; 63 
Matsuda et al., 2001). Moreover, a population of αGalCer-reactive NKT cells that express 64 
Vα10 TCR and has a distinct lipid-recognition capacity has been identified (Uldrich et al., 65 
2011). In humans, while the majority of αGalCer-binding iNKT cells express the prototypical 66 
Vα24Vβ11 TCR, populations of atypical NKT cells have been found in the blood, with cells 67 
expressing a range of TCRα and TCRβ chains that show differential recognition of lipid 68 
antigens (Le Nours et al., 2016; Matulis et al., 2010). Therefore, the so-called invariant NKT 69 
cells constitute a polyclonal population with a broader antigen recognition capacity than 70 
previously assumed. Since iNKT cells are tissue-resident cells an important question 71 
remains regarding whether the iNKT cell TCR repertoire (and consequently antigen 72 
specificity) is related to their anatomical location and/or shaped by the antigens that these 73 
cells encounter in peripheral tissues. Similarly, whether the iNKT cell population changes in 74 
response to environmental challenges including infection, vaccination, alterations in the diet 75 
or antibiotic use is unknown. 76 
  77 
While the TCR repertoire is determined during thymic selection the relevance of post-thymic 78 
TCR shaping has been demonstrated for both conventional CD4+ T cells and regulatory T 79 
cells (Tregs). Accordingly, the TCR repertoire of thymic and peripheral CD4+ T cells (or that 80 
of recent thymic emigrants (RTE) and mature naïve T cells) are not identical, suggesting that 81 
certain clones are preferentially enriched and/or deleted in the periphery (Correia-Neves et 82 
al., 2001; Houston & Fink, 2009). Similarly, the TCR repertoire of natural Tregs is unique for 83 
individual tissues, is shaped by the local antigenic landscape and controls Treg-mediated 84 
tolerance to the tissues (Lathrop et al., 2011; Lathrop et al., 2008). In the case of iNKT cells, 85 
CCR7+ iNKT cell precursors are known to emigrate from the thymus and home to peripheral 86 
tissues where they undergo further maturation (Wang & Hogquist, 2018). In this way 87 
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peripheral signals presumably shape the iNKT cell population into a mature iNKT cell pool. 88 
However, whether they impact the antigen recognition capacity of iNKT cells in their tissues 89 
of residency remains unknown.  90 
 91 
 92 
Here, we have investigated the impact of the anatomical location in the peripheral iNKT cell 93 
population. By combining flow-cytometry analyses, lipid-loaded tetramers and RNAseq 94 
experiments we demonstrate that the iNKT cell TCR repertoire is highly polyclonal and it is 95 
different for iNKT cells resident in various tissues resulting in differential lipid antigen 96 
recognition. In line with this, the repertoire of iNKT RTE is distinct from that of mature iNKT 97 
cells suggesting that local signals shape the mature iNKT cell population. Accordingly, the 98 
basal activation, proliferation and clonal expansion of iNKT cells is dictated by anatomical 99 
location. Moreover, the repertoire and phenotype of human iNKT cells is also different for 100 
cells found in various anatomical locations. Thus, our data uncovers a novel mechanism of 101 
tissue-specific immunoregulation that underpins the antigen-specificity of iNKT cells in 102 
different sites.  103 
 6 
RESULTS  104 
Distinct TCR repertoire and clonal expansion for iNKT cells from various tissues 105 
The majority of αGalCer-reactive iNKT cells express an invariant TCR α-chain (Vα14-Jα18), 106 
however the Vβ chain usage is variable, with higher percentages of cells expressing Vβ7 or 107 
Vβ8 chains. Thus, to evaluate whether the TCR repertoire of iNKT cells is related to their 108 
anatomical location we examined the expression of Vβ7 and Vβ8.1/8.2 by iNKT cells from 109 
various lymphoid tissues of WT C57BL/6 mice. We identified iNKT cells from thymus, 110 
spleen, inguinal lymph node (iLN) and mesenteric lymph node (mLN) by PBS57-loaded 111 
CD1d tetramer (CD1d-tet-PBS57; being PBS57 an analogue of αGalCer) and TCRβ co-112 
staining (Figure 1; Figure 1- figure supplement 1A). Within the iNKT cell population we found 113 
that the percentage of Vβ usage varied according to anatomical location, and particularly 114 
iNKT cells from LNs showed decreased percentage of cells using Vβ8.1/8.2 chains and 115 
increased percentages of cells using “other” Vβs (other than Vβ7 or Vβ8.1/8.2) in 116 
comparison with cells from thymus or spleen (Figure 1A). We also observed significant 117 
differences in TCRVβ usage for iNKT cells identified in non-lymphoid tissues including liver, 118 
lung and small intestinal lamina propria (SI-LP) (Figure 1- figure supplement 1A and 1B). 119 
Interestingly, we detected the same shift in TCRVβ usage after iNKT cells (enriched from 120 
spleen and thymus) were adoptively transferred into congenic mice. Twelve days after 121 
transfer, donor cells found in LNs showed a decreased frequency of TCRVβ8.1/8.2 usage in 122 
comparison with cells found in the spleen, recapitulating the TCRVβ usage of endogenous 123 
iNKT cells (Figure 1- figure supplement 1C). Thus, all together this data indicates that the 124 
TCRβ repertoire of peripheral iNKT cells varies according to their anatomical location.  125 
 126 
To get an unbiased overview of the properties and TCR repertoire of peripheral iNKT cells, 127 
we sort-purified iNKT cells from various lymphoid tissues (thymus, spleen, iLN, mLN), and 128 
performed whole transcriptome RNA sequencing (RNAseq). This method, not only enabled 129 
identification of the differentially expressed genes and pathways in iNKT cells from individual 130 
tissues, but also analyses of iNKT cell clonality and TCR repertoire (Brown et al., 2015; Li et 131 
 7 
al., 2016). Thus, using our RNAseq data we took advantage of MiXCR software to identify 132 
the CDR3 sequences, V, D and J segments and the repertoires for iNKT cells isolated from 133 
individual tissues (Bolotin et al., 2015; Bolotin et al., 2013). With this approach, we identified 134 
a total of approximately 80,000 (productive) TCR sequences (Figure 1- figure supplement 135 
2A) obtained from 4 biological replicates per tissue. As expected, the majority of TRAV 136 
sequences (>96%) identified in all of the tissues corresponded to the canonical TRAV11-137 
TRAJ18 rearrangement (Vα14-Jα18) and showed highly conserved CDR3 sequences 138 
(Figure 1- figure supplement 2B). In agreement with our flow-cytometry data TRB29 (Vβ7) 139 
and TRB13 (Vβ8) segments represented the majority of TCRβ usage in all the tissues and 140 
the percentage of usage for each gene differed between tissues (Figure 1B-1C, Figure 1- 141 
figure supplement 2B). Specifically, the percentage of the most abundant TRBV13-2 gene 142 
(Vβ8.2) was decreased in samples from LNs in comparison with spleen or thymus and we 143 
also detected significant differences between tissues in the frequency of TRBV29 (Vβ7) and 144 
TRBV1 (Vβ2; Figure 1B). Moreover, we detected a highly diverse TRBJ usage and TRBV-145 
TRBJ pairing with notable differences for iNKT cells from individual tissues (Figure 1C), 146 
which could suggest the existence of preferred TRBV-TRBJ pairing and/or the expansion (or 147 
deletion) of certain iNKT cell clones.  148 
 149 
We found the CDR3 sequences to be highly polyclonal without conserved motives or 150 
specific residues associated with individual tissues (Figure 1D, Figure 1- figure supplement 151 
3). Comparative analyses of length and physicochemical properties for CDR3 amino acid 152 
(aa) sequences (including hydrophobicity (based on the Kyte–Doolittle scale (Kyte & 153 
Doolittle, 1982)), isoelectric point (pI, according to EMBOSS (Rice et al., 2000)), frequency 154 
of polar (D, E, H, K, N, Q, R, S, T), aliphatic (A, I, L, V) or aromatic (F, H, W, Y) residues) did 155 
not find significant differences in sequences from iNKT cells isolated from various tissues 156 
(Figure 1- figure supplement 3). However, when we assessed the distribution of the iNKT 157 
cell TCR clonotype size (the proportion of CDR3 sequences which occur once, twice, etc. 158 
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in a specific tissue), we detected a higher clonal size for iNKT cells from iLN and mLN in 159 
comparison with splenic and thymic iNKT cells (Figure 1E-1G). Accordingly, while in spleen 160 
and thymus CDR3sequences appearing only once in our data-set represented around 161 
65% of the total sequences, this percentage decreases to 50% in mLN and 40% in iLN 162 
(Figure 1E-F). We further assessed individual iNKT TCR repertoires for evidence of clonal 163 
expansion by using cumulative frequency curves to measure the 25 most prevalent 164 
clonotypes (Figure 1G). These analyses provided evidence for increase in clone sizes in 165 
iLN and mLN TCR repertoires in comparison with iNKT cells from spleen or thymus.  166 
 167 
Thus, all together this data demonstrates that the TCRVβ repertoire and clonal expansion of 168 
iNKT cells varies according to their anatomical location. 169 
 170 
Peripheral shaping of the iNKT cell TCR repertoire  171 
Once selected in the thymus, the TCR repertoire of conventional T cells is further shaped in 172 
peripheral lymphoid organs possibly through differential modulation of the expansion and 173 
survival of individual T cells (Correia-Neves et al., 2001; Houston & Fink, 2009). To analyse 174 
whether the TCR repertoire of iNKT cells is modulated after their arrival to peripheral organs, 175 
we compared the TCRVβ usage for iNKT cells just arriving to the tissues after thymic 176 
selection (iNKT RTE) with that of resident iNKT cells that have been in the tissues for 177 
several weeks (Figure 2, Figure 2 - figure supplement 1). To identify iNKT RTE we took 178 
advantage of Rag2GFP reporter mice (Boursalian et al., 2004). In these animals GFP 179 
identifies RTE in peripheral tissues and the label is brightest in the youngest RTEs and 180 
decays over time until it can no longer be detected on T cells that have been in the periphery 181 
for more than 3 weeks (Boursalian et al., 2004). We identified small populations of GFP+ 182 
iNKT RTE in all the analysed tissues of Rag2GFP reporter mice (Figure 2A). In the thymus the 183 
majority of iNKT cells are mature tissue-resident cells (GFP-) but there is a population of 184 
GFP+ iNKT cells that also includes cells in early developmental stages (Wang & Hogquist, 185 
2018). In agreement with this, GFP expression was higher in thymic iNKT RTE but 186 
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comparable in RTE from spleen or LNs (Figure 2A). We found that the TCRVβ usage was 187 
different when we compared RTE and resident (GFP-) iNKT cells within the peripheral 188 
tissues of Rag2GFP animals (Figure 2B) with a consistent increase in the percentage of 189 
TCRVβ7+ in the resident iNKT cell population compared to the recently arrived counterparts.  190 
 191 
To further explore the peripheral shaping of the iNKT cell repertoire, we took advantage of a 192 
recently described strategy to identify iNKT cell precursors (CCR7+PD-1-Qa2low iNKT cells) 193 
which have been shown to emigrate from the thymus to the periphery where they terminally 194 
differentiate (Wang & Hogquist, 2018). Using this combination of markers, we detected 195 
populations of iNKT precursors in thymus and spleen (as previously described), but also in 196 
peripheral LNs (Figure 2 - figure supplement 1A). Notably, CCR7+PD1-Qa2low and 197 
Rag2GFP+ iNKT cell populations don’t fully overlap and while Rag2GFP+ NKT cells are 198 
enriched for CCR7+ cells, not all CCR7+ NKT cells are RTE (Figure 2 - figure supplement 199 
1B) (Wang & Hogquist, 2018). Nevertheless, when we compared the TCRVβ usage for 200 
CCR7+PD-1- iNKT cell precursors and “mature” iNKT cells (excluded from the CCR7+PD-1- 201 
gate) we observed consistent changes in Vβ usage with an increase in the percentage of 202 
TCRVβ7+ cells in the mature iNKT cell population compared to the recently arrived 203 
counterparts (Figure 2 - figure supplement 1C). Thus, these results suggest that after arrival 204 
to the tissues iNKT cells are exposed to local signals that shape the newly arrived iNKT cell 205 
population into a mature iNKT cell pool with a distinct TCR repertoire.  206 
 207 
 208 
LN iNKT cells show increased proliferation which is associated with a distinct TCR 209 
repertoire 210 
To investigate the processes shaping the iNKT population in the different lymphoid tissues 211 
we studied the gene expression profile for iNKT cells isolated from thymus, spleen, mLN and 212 
iLN (Figure 3, Figure 3 - figure supplement 1A,B). Transcriptome analyses showed around 213 
200-400 genes that were differentially expressed amongst iNKT cells from various tissues 214 
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(e.g. mLN and splenic iNKT cells differed by ~200 genes; adjusted p value <0.01, fold 215 
change >1.5) (Figure 3A). Compared to spleen iNKT cells, cells from thymus, iLN and mLN 216 
showed differential expression of transcripts encoding transcriptional regulators (e.g. Fos, 217 
Fosb, Egr1, Egr3), nuclear factors (e.g. Na4r1, Tcf7), cytokine/chemokine receptors (e.g. 218 
Ccr8, Ccr4, Il12r2b) and molecules related to cytotoxicity (e.g. Gzma, Klrg1).  Interestingly, 219 
iNKT cells from iLN and mLN (but not from thymus) showed upregulation of genes related to 220 
T cell activation/TCR signalling including Na4r1 (Nur77), Icos, Cd28, Fos, Fosb as well as 221 
the chemokine receptors Ccr4 and Ccr8 which are upregulated after TCR-mediated 222 
activation (D'Ambrosio et al., 1998; Sallusto et al., 1999) (Figure 3B). Conversely, negative 223 
regulators of TCR signalling such as Dok2 or Ptpn22 were downregulated in LN cells vs 224 
iNKT cells from spleen or thymus (Figure 3B). Indeed, gene ontology enrichment analysis 225 
comparing the transcriptome of LN iNKT cells with cells from spleen and thymus, 226 
demonstrated significant enrichment in LN iNKT cells for genes encoding molecules related 227 
to positive regulation of T cell activation and positive regulation of cellular proliferation 228 
(Figure 3 - figure supplement 1A,B). Hence, these results suggest that the basal activation of 229 
iNKT cells is distinct for cells found in various lymphoid tissues. 230 
 231 
Amongst the significantly changed genes liked to T cell activation, the nuclear receptor 232 
transcription factor Nur77 (Nr4a1) is induced rapidly upon TCR stimulation and in a manner 233 
proportional to TCR signalling intensity (Moran et al., 2011) and was found to be upregulated 234 
in LN iNKT cells in comparison with thymic and splenic iNKT cells. We confirmed this result 235 
by taking advantage of Nur77GFP reporter mice in which we observed that iNKT cells from 236 
mLN and iLN express high levels of GFP while cells from spleen and thymus are 237 
predominantly GFP- (Figure 3C). Furthermore, the activation markers ICOS and CD25 and 238 
the chemokine receptor CCR8 were also found to be expressed at higher levels in LN iNKT 239 
cells in comparison with cells from spleen (Figure 3C). As LN iNKT cells showed an 240 
enrichment of genes involved in positive regulation of cellular proliferation we analysed iNKT 241 
cell proliferation by measuring the expression of the proliferation marker Ki-67 and the 242 
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incorporation of EdU in vivo (Figure 3D-F). We detected a consistently higher expression of 243 
Ki-67 (Figure 3D-E) and higher EdU incorporation (48 h after EdU injection; Figure 3F) in LN 244 
iNKT cells vs. splenic or thymic cells, confirming a higher degree of local proliferation for 245 
iNKT cells in LNs. Thus, in homeostatic conditions LN iNKT cells show increased TCR 246 
signalling, activation and proliferation in comparison to splenic or thymic cells.  247 
 248 
To investigate whether the increased proliferation of LN iNKT cells is related to their 249 
increased clonal expansion and contributes to their distinct TCRβ repertoire we analysed the 250 
TCRVβ usage of proliferating (EdU+) vs non-proliferating (EdU-) iNKT cells after EdU 251 
administration in vivo (Figure 3G, Figure 3 - figure supplement 1C). These experiments 252 
showed a bias in the TCRVβ repertoire, with an enrichment on Vβ7 and a decrease in 253 
Vβ8.1/8.2 usage in proliferating vs non-proliferating cells. In agreement with this data, when 254 
we compared the TRBV repertoire of sequences present only once in our RNAseq-derived 255 
dataset vs more abundant sequences (2 copies or more), we detected increased frequency 256 
of TRBV29 (Vβ7) and decreased TRBV13-2 gene usage (Vβ8.2) in abundant vs low-copy 257 
sequences (Figure 3H). Thus, this data suggests that LN iNKT cells have increased basal 258 
activation and proliferation that contribute to shape the local iNKT cell TCR repertoire. 259 
 260 
The anatomical location governs the basal activation and TCRV usage of all iNKT 261 
cell subsets 262 
iNKT cells are a heterogeneous population that can be classified into several subsets based 263 
on the expression of signature transcription factors: NKT1 (T-bet+); NKT2 (PLZFhi); NKT17 264 
(RORγt+)(Engel et al., 2016; Lee et al., 2013). Because iNKT cell subpopulations are 265 
present at different proportions in the various lymphoid organs we evaluated whether the 266 
changes in proliferation, basal activation and TCR repertoire could be due to different iNKT 267 
subsets present in those tissues. As previously reported, in C57BL/6 mice we found that 268 
NKT1 cells represent the majority of iNKT cells in thymus, spleen, mLN and iLN, but we also 269 
detected significant proportions of NKT2s and NKT17s in LNs (Figure 4A). Importantly, we 270 
 12 
found that the increased expression of activation and proliferation markers in LN iNKT cells 271 
was evident for all iNKT cell subpopulations (Figure 4B). As such, the expression of Ki-67, 272 
Nur77, ICOS and CD25 was higher in NKT1, NKT2 and NKT17 cells from LNs vs their 273 
splenic counterparts, indicating that the tissue environment controls the basal activation and 274 
proliferation of iNKT cells regardless of the subset to which they belong. In the same line, we 275 
found that the anatomical location led to variation in TCRVβ usage within individual iNKT cell 276 
subsets (Figure 4C). For instance, within the NKT1 population we detected a lower 277 
frequency of Vβ8.1/8.2 in cells from the LNs vs spleen or thymus. Likewise, Vβ7 usage was 278 
significantly different in all subsets when comparing cells from different tissues. In line with 279 
these results, we also detected significant differences in TCRVβ usage associated with the 280 
tissue of residency when iNKT cells were subdivided on the basis of their expression of CD4 281 
and/or NK1.1 (Figure 4 - figure supplement 1). Thus, all together this data indicates that the 282 
anatomical location shapes the basal activation, proliferation and TCR repertoire of all iNKT 283 
cell subsets. 284 
 285 
Differential lipid antigen recognition for iNKT cells in peripheral tissues 286 
Next, we investigated the functional relevance of the distinct TCRβ repertoire for iNKT cells 287 
found in different anatomical locations. Since the TCRβ usage in iNKT cells modulates lipid 288 
antigen recognition (Cameron et al., 2015; Florence et al., 2009) we investigated the antigen 289 
binding capacity for iNKT cells in individual tissues. To do this, we costained iNKT cells from 290 
various tissues (thymus, spleen, mLN, iLN, SI-LP, liver, lung) with CD1d-tet-PBS57 and 291 
CD1d-tetramers loaded with different glycolipid antigens including the αGalCer analogue 292 
OCH, αGlucosylCeramide (C26; αGlcCer), ßGlucosylCeramide (C24; βGlcCer) and 293 
ßGalactosylCeramide (C12; βGalCer). Within the CD1d-tet-PBS57+ iNKT cell population we 294 
identified distinct populations of iNKT cells binding OCH and αGlcCer in all analysed tissues 295 
(Figure 5A-5B, Figure 5 -figure supplement 1), but not βGlcCer or βGalCer (data not shown). 296 
Interestingly, the percentages of cells binding to the various lipid antigens was different 297 
amongst tissues (Figure 5A-5B, Figure 5 -figure supplement 1). For instance, while most 298 
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iNKT cells bind αGlcCer and OCH in thymus, spleen, liver and lung, in iLN, mLN and SI-LP 299 
we identified clear populations of αGlcCer- and OCH- iNKT cells (Figure 5A-5B, Figure 5 -300 
figure supplement 1A-B). Also, the TCRVβ usage shapes antigen binding as the proportion 301 
of Vβ7+ and Vβ8.1/8.2+ iNKT cells were skewed when comparing OCH+ vs OCH- iNKT cells 302 
or αGlcCer+ vs αGlcCer- iNKT cells (Figure 5C, Figure 5 -figure supplement 1C). 303 
Consequently, we detected a strong correlation between the percentage of Vβ8+ iNKT cells 304 
and the binding to OCH or αGlcCer (Figure 5D, Figure 5 -figure supplement 1D). Thus, this 305 
data indicates that the distinct TCRβ repertoire found in iNKT cells from various anatomical 306 
locations relates to their differential capacity for lipid antigen recognition. 307 
 308 
It is well established that in conventional T cells there are age-dependent changes in the 309 
TCR repertoire that lead to impaired immune responses (Yager et al., 2008). Hence, we 310 
analysed the effect of age in iNKT cells by measuring the TCRVβ usage and lipid-binding 311 
capacity for iNKT cells in the tissues of 2, 6 and 11-week-old WT C57BL/6 mice (Figure 5E-312 
5F). We detected significant changes in TCRVβ usage associated to the age of the mice. 313 
For instance, the percentage of Vβ8.1/8.2+ iNKT cells decreases over time in iLN and mLN, 314 
whereas the percentage of cells expressing other Vβs in those tissues increases (Figure 315 
5E). The TCR changes over-time are more evident in LNs in comparison with the spleen and 316 
the differences in TCRVβ usage for LN iNKT cells are more prominent in adult mice (6w vs 317 
11w) than in younger animals (2w vs 6w). Importantly, the changes in the frequency of 318 
Vβ8.1/8.2+ iNKT cells in older mice correlate with the capacity of the cells to bind αGlcCer-319 
loaded CD1d tetramers (Figure 5F). Hence, in the LNs both the frequency of Vβ8.1/8.2+ 320 
iNKT cells and that of αGlcCer+ cells decrease as mice age. Thus, this data demonstrates a 321 
differential lipid antigen recognition capacity for iNKT cells from various tissues, which is 322 
shaped by age. 323 
 324 
The iNKT cell TCR repertoire changes in response to immunisation and 325 
environmental challenges  326 
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We next explored the stability of the peripheral iNKT cell TCR repertoire in response to 327 
antigenic challenges and environmental changes. To analyse whether immunisation with 328 
lipid antigens induces lasting changes in the iNKT TCR repertoire we injected mice with the 329 
lipid antigen OCH and followed the changes in the iNKT cell population at 3 or 13 days after 330 
immunisation (Figure 6A-6D). Three days after OCH administration we detected strong 331 
proliferation of iNKT cells in spleen and LNs, resulting in an increase in Ki-67 expression and 332 
in the frequency of iNKT cells in comparison with control (PBS injected) mice (Figure 6A-333 
6C). The vast majority (~80%) of highly proliferative iNKT cells (Ki-67hi) expressed 334 
TCRVβ8.1/8.2. As a result, we detected a global change in the TCRVβ usage for the local 335 
iNKT cell populations in comparison with control mice with reduced frequency of TCRVβ7+ 336 
iNKT cells which are replaced by TCRVβ8.1/8.2+ cells (Figure 6D). Thirteen days after OCH 337 
administration Ki-67 expression and iNKT cell frequency returned to basal levels (Figure 6B-338 
6C). However, the TCR repertoire of the iNKT cell population was still significantly different 339 
from control mice with increased frequency of TCRVβ8.1/8.2+ and reduced TCRVβ7+ iNKT 340 
cells (Figure 6D). In line with these results, we also detected significant changes in the TCR 341 
repertoire of iNKT cells after immunisation with GalCer (Figure 6- figure supplement 1). In 342 
response to this lipid, the frequency of TCRVβ8.1/8.2+ iNKT cells increased at the expense 343 
of Vβother+ cells while the frequency of Vβ7+ cells remained unchanged (Figure 6- figure 344 
supplement 1). Interestingly, after antigen stimulation (both in vitro and in vivo) Vβ7+ iNKT 345 
cells showed reduced secretion of cytokines in comparison with Vβ8.1/8.2+ or Vβother+ cells 346 
(Figure 6- figure supplement 2). Thus, all together this data indicates that the TCRV usage 347 
of iNKT cells is associated with their distinct activation and proliferation in response to 348 
antigen stimulation. As a result, exposure to lipid antigens induces a restructure in the 349 
repertoire of the iNKT cell population that is maintained even after proliferation has ceased 350 
and the population has contracted. 351 
 352 
Commensal-derived products are known to modulate the numbers and phenotype of iNKT 353 
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cells (An et al., 2014; Saez de Guinoa et al., 2018; Wingender et al., 2012). Thus, we 354 
hypothesized that changes in commensal bacteria could also lead to a restructure of the 355 
iNKT cell TCR repertoire. To address this, we treated 5-week old mice with antibiotics in the 356 
drinking water for 6 weeks and analysed the TCRVβ usage in iNKT cells in those animals at 357 
11 weeks of age (vs. control mice; Figure 6E). Interestingly, we found that antibiotic 358 
treatment resulted in a small but significant increase of the frequency of iNKT cells in mLN 359 
and iLN (Figure 6 - figure supplement 3). Moreover, we detected changes in the TCRVβ 360 
usage of the iNKT cell population with a significant increase in the percentage of Vβ8.1/8.2+ 361 
iNKT cells in the gut-draining mLN. Added to this, we also detected changes in TCRVβ 362 
usage for mLN iNKT cells when we compared cells from the tissues of 6-week old germ-free 363 
(GF) animals with those of conventional (specific pathogen free, SPF) mice (Figure 6F). It is 364 
worth noting that changes in TCRVβ usage in iNKT cells were not identical in GF or 365 
antibiotic-treated mice, possibly due to the incomplete depletion of commensal bacteria and 366 
to the drastic changes in the surviving commensal populations induced by antibiotic 367 
treatment (Hill et al., 2010). Thus, these data suggest that modifications in the intestinal 368 
microbiota lead to changes on the TCR repertoire of iNKT cells. 369 
 370 
Different phenotype and TCR repertoire for iNKT cells from human tonsils and blood 371 
Finally, we explored whether the differences in repertoire and phenotype found in murine 372 
iNKT cells resident in various tissues were also present in humans. To do this, we compared 373 
the phenotype and the TCRVα and TCRVβ usage of PBS57-binding iNKT cells from human 374 
blood and tonsils (Figure 7). The percentage of CD1d-tet-PBS57+ iNKT cells (from total 375 
CD3+ cells) in the blood was approximately 0.1%, around 10 times higher than the 376 
percentages of iNKT cells found in tonsils (Figure 7A). Co-staining with CD4 and CD8 377 
revealed variable populations of cells, including CD4+, CD8+ and double-negative (DN) iNKT 378 
cells (Figure 7B). The proportion of each of these populations was variable amongst donors, 379 
but we detected a consistently higher frequency of CD4+ iNKT cells within the tonsil 380 
population (mean= 72.4%) compared to blood (mean= 46.6%). Moreover, the expression of 381 
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the activation markers CD25 and CD69 was also variable, but we detected an increase in 382 
the proportion of CD69+ iNKT cells within the tonsils (Figure 7C), confirming a different 383 
phenotype for iNKT cells found in tonsils vs. blood. 384 
 385 
While the majority of human iNKT cells express the prototypical Vα24Vβ11 TCR, 386 
populations of atypical NKT cells have been found in human blood, representing up to 10% 387 
of the iNKT cell population (Le Nours et al., 2016). These cells retain the capacity to bind 388 
CD1d-tet-PBS57 but express a range of TCRα and β chains that result in differential 389 
recognition of lipid antigens. Thus, we analysed the usage of Vα24 and Vβ11 within the 390 
iNKT cell populations from tonsils and blood (Figure 7D-7E). As previously described, we 391 
found that the majority of CD1d-tet-PBS57+Vα24+ iNKT cells express TCRVβ11 in both 392 
blood and tonsils. Similarly, the majority of CD1d-tet-PBS57+Vβ11+ iNKT cells expressed 393 
Vα24. However, we found a variable proportion (0-10%) of iNKT cells lacking expression of 394 
Vα24 or Vβ11 in blood and tonsils. These atypical iNKT cell populations were found at 395 
significantly higher frequency in the tonsils in comparison to blood. For instance, Vα24-Vβ11+ 396 
iNKT cells represent up to 10% of the iNKT cell population in tonsils while they comprised 397 
between 0 and 3% of iNKT cells in blood (Figure 7D-7E). Thus, all together this data 398 
demonstrates that the TCR repertoire and phenotype of human iNKT cells are distinct for 399 
cells found in different anatomical sites. 400 
 401 
 402 
DISCUSSION 403 
Tissue-resident iNKT cells are known to have unique properties and functions related to the 404 
tissues in which they reside, yet the antigen specificity of these populations in individual 405 
tissues remains unknown. Here, we found that the basal activation, proliferation, TCR 406 
repertoire and antigen specificity of peripheral iNKT cells are modulated by their anatomical 407 
location. While the TCR of αGalCer-reactive NKT cells has been described as “invariant”, 408 
recent studies have identified variability in TCR Vα and Vβ chains in both the mouse and 409 
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human repertoires resulting in differential capacity for lipid antigen recognition (Cameron et 410 
al., 2015; Le Nours et al., 2016; Matsuda et al., 2001). In agreement with this data, we found 411 
that the Vβ and Jβ usage, Vβ-Jβ pairing and CDR3β in iNKT cells are highly variable and 412 
relate to their capacity for lipid recognition. Thus, the so-called invariant NKT cell population 413 
expresses a variable TCRVβ repertoire that differs according to their anatomical location and 414 
results in differential antigen recognition capacity for iNKT cells resident in individual tissues. 415 
Importantly, our data confirms that anatomical differences also apply to human iNKT cells. 416 
Thus, we found increased frequencies of atypical iNKT cells (Vα24- or Vβ11-) in tonsils vs 417 
blood while the frequency of CD4+ iNKT cells and CD69+ iNKT cells was also different in 418 
those anatomical locations. This data is particularly relevant, as the vast majority of studies 419 
related to human iNKT cells are focused on cells isolated from the blood that may not fully 420 
recapitulate the phenotype and specificity of iNKT cells residing in peripheral tissues. 421 
 422 
After selection in the thymus, peripheral CD4+ T cell survival requires the expression of 423 
MHC. In the case of iNKT cells, while thymic development is CD1d-dependent, CD1d 424 
expression and the iNKT TCR have been proposed to be dispensable for the survival of 425 
peripheral iNKT cells (Matsuda et al., 2002; Vahl et al., 2013). However, CD1d-TCR signals 426 
are required for post-thymic maturation of iNKT cells in the periphery (e.g. NK1.1- to NK1.1+ 427 
transition)(McNab et al., 2005) and CD1d expression on hepatocytes and CD11c+ cells 428 
regulates the phenotype and numbers of iNKT cells in liver and gut respectively (Saez de 429 
Guinoa et al., 2018; Zeissig et al., 2017). Thus, this suggests that while CD1d-TCR signals 430 
might not be required for iNKT cell survival, they can shape the peripheral iNKT cell 431 
population. Our data supports a model by which after selection in the thymus, the TCR 432 
repertoire of the iNKT cell population is subjected to further shaping in the periphery 433 
resulting in differential capacity for lipid recognition by iNKT cells resident in individual 434 
tissues. Another (but not exclusive) explanation for the tissue-skewed TCR repertoire could 435 
be that after thymus export the TCR of individual iNKT cells is linked to homing in specific 436 
tissues. However, it has been shown that the iNKT cell TCR specificity doesn’t significantly 437 
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affect iNKT cell homing in the tissues. Accordingly, iNKT cells expressing a variety of 438 
TCRVβ chains and CDR3β sequences generated in retrogenic or transnuclear mice were 439 
found to home efficiently in a variety of tissues irrespectively of their TCR specificity or Vβ 440 
usage (Clancy-Thompson et al., 2017; Cruz Tleugabulova et al., 2016). In line with this, our 441 
own analyses of the iNKT cell CDR3β sequences did not reveal any obvious correlations 442 
between specific residues or their physicochemical properties and their tissue of origin. 443 
Thus, while our data doesn’t preclude that after thymic egress certain iNKT cell clones may 444 
preferentially home in specific tissues, it supports a model in which local signals shape the 445 
TCR repertoire and specificity of the iNKT cell population after their arrival to the tissues.  446 
 447 
Tissue-specific programming has been described for various tissue-resident immune cell 448 
populations including macrophages, innate lymphoid cells or Tregs whose properties are 449 
controlled by local tissue-derived signals (Miragaia et al., 2019; Okabe & Medzhitov, 2014). 450 
In the case of iNKT cells, previous studies have shown that while cells from spleen and liver 451 
display relatively similar transcriptional programs, adipose tissue iNKT cells present a 452 
distinct transcriptional profile associated with a unique (PLZF-independent) developmental 453 
pathway (Lynch et al., 2015). Our data shows a relatively similar transcriptome for iNKT cells 454 
isolated from thymus, spleen and LNs with only around 200-400 genes differentially 455 
expressed in these tissues (in contrast to the thousands of genes differentially expressed by 456 
adipose vs. splenic iNKT cells (Lynch et al., 2015)). This suggests that while iNKT cells 457 
found in various lymphoid tissues likely share the same developmental program, local 458 
signals in the tissues in which they reside shape their phenotype and functions. Accordingly, 459 
iNKT cells isolated from LNs show differential expression of genes related to T cell 460 
activation, TCR signalling and proliferation indicating that in the LNs iNKT cells are 461 
recognising lipid antigens (e.g. endogenous or from commensals) that are not seen by iNKT 462 
cells residing in spleen or thymus in homeostatic conditions. Thus, it is feasible to speculate 463 
that the catalogue of (endogenous and exogenous) lipids presented by CD1d in specific 464 
tissues could contribute to shape the population of iNKT cells resident in those tissues. 465 
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Added to this, it is likely that other signals (such as cytokines or hormones) also contribute to 466 
modulate the phenotype and function of tissue-resident iNKT cells (Holzapfel et al., 2014; 467 
Matsuda et al., 2002). 468 
 469 
The observation that the iNKT cell TCR repertoire is shaped by anatomical location 470 
resembles the unique repertoire observed for natural Tregs which is also shaped by 471 
environmental antigens possibly controlling Treg-mediated tolerance to the specific tissue 472 
environment (Lathrop et al., 2011; Lathrop et al., 2008). The tight control of CD1d-dependent 473 
lipid presentation and peripheral iNKT cell homeostasis are also critical to prevent local 474 
inflammation. Accordingly, dysregulation of intestinal iNKT cell homeostasis as a 475 
consequence of alteration in commensal lipids results in increased susceptibility to intestinal 476 
inflammation (An et al., 2014; Olszak et al., 2012; Wingender et al., 2012). Also, CD1d-lipid 477 
presentation by hepatocytes controls peripheral induction of iNKT cell tolerance in the liver, 478 
protecting from hepatic inflammation (Zeissig et al., 2017). Importantly, changes in the iNKT 479 
cell TCR repertoire have been also associated with autoimmune diseases as is the case in 480 
patients with diabetes (Tocheva et al., 2017) and rheumatoid arthritis (Mansour et al., 2015) 481 
and transgenic mice over-expressing an autoreactive NKT cell-TCR develop spontaneous 482 
colitis (Liao et al., 2012). Thus, the local tissue-specific regulation of iNKT cell immunity may 483 
have important implications for the development and progression of autoimmune and 484 
inflammatory processes. 485 
 486 
In summary, our study demonstrates that local signals shape the populations of tissue-487 
resident lymphocytes and suggests that exposure to different immunisations, microbial 488 
infections or environmental changes can impact and shape the host’s iNKT cell TCR 489 
repertoire. These findings may inform future development of novel therapies based on the 490 
manipulation of iNKT cells for vaccination or immunotherapy. 491 
 492 
 493 
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MATERIALS AND METHODS 494 
Key resources table 495 
Reagent type (species) 
or resource 
Designation 
Source or 
reference 
Identifiers 
Additi
onal 
inform
ation 
strain, strain background 
(Mus musculus) 
Rag2-GFP:  
Tg(Rag2-EGFP)1Mnz 
PMID: 
10458165 
MGI:3784416 
 
strain, strain background 
(Mus musculus) 
Nur77-GFP: C57BL/6-
Tg(Nr4a1-
EGFP/cre)820Khog/J 
PMID: 
21606508 
MGI:5007644 
 
strain, strain background 
(Mus musculus) 
CD1d-KO: 
Del(3Cd1d2-
Cd1d1)1SbpJ 
PMID: 
14632651 
MGI:5582477 
 
antibody 
PBS57-loaded CD1d-
tetramer (mouse) 
NIH Tetramer 
Core Facility 
https://tetramer.yerkes.emo
ry.edu 
(1: 
1000) 
antibody 
anti-mouse B220  
(rat monoclonal) 
 
BioLegend 103224 (1:200) 
antibody 
anti-mouse CD8
(rat monoclonal) 
BioLegend 100714 (1:200) 
antibody 
anti-mouse CD11b 
(rat monoclonal) 
BioLegend 101226 (1:200) 
antibody 
anti-mouse CD11c 
(armenian hamster 
monoclonal) 
BioLegend 117323 (1:200) 
antibody 
anti-mouse PLZF 
(armenian hamster 
monoclonal) 
BioLegend 145807 (1:200) 
antibody 
anti-mouse RORt 
(mouse monoclonal) 
BD 
Biosciences 
564722 (1:200) 
antibody 
anti-mouse T-bet 
(mouse monoclonal) 
BioLegend 644823 (1:200) 
antibody 
anti-mouse TCR
(armenian hamster 
monoclonal) 
BioLegend 109233 (1:200) 
antibody 
anti-mouse V7 
(rat monoclonal) 
BioLegend 118306 (1:200) 
antibody 
anti-mouse V8.1/8.2 
(rat monoclonal) 
eBiosciences 46-5813-80 (1:200) 
antibody 
anti-mouse CCR7 
(rat monoclonal) 
BioLegend 120105 (1:100) 
antibody 
anti-mouse PD1 
(rat monoclonal) 
BioLegend 135219 (1:200) 
antibody 
anti-mouse Qa2 
(mouse monoclonal) 
BD 
Biosciences 
743312 (1:200) 
antibody 
anti-mouse CD25 
(rat monoclonal) 
BioLegend 102015 (1:200) 
antibody 
anti-mouse Ki-67 
(rat monoclonal) 
BioLegend 652425 (1:200) 
antibody 
anti-mouse ICOS 
(rat monoclonal) 
BioLegend 117405 (1:200) 
antibody 
anti-mouse CD4 
(rat monoclonal) 
BioLegend 100433 (1:200) 
antibody 
anti-mouse NK1.1 
(mouse monoclonal) 
eBiosciences 11-5941-85 (1:200) 
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antibody 
anti-mouse CD27 
(armenian hamster 
monoclonal) 
BioLegend 124215 (1:200) 
antibody 
anti-mouse CCR6 
(armenian hamster 
monoclonal) 
BioLegend 129809 (1:200) 
antibody 
anti-mouse CD45.1 
(mouse monoclonal) 
BioLegend 110731 (1:200) 
antibody 
anti-mouse CD45.2 
(mouse monoclonal) 
BioLegend 109805 (1:200) 
antibody 
anti-mouse CCR8 
(rat monoclonal) 
BioLegend 150320 (1:200) 
antibody 
anti-mouse IL-4 
(rat monoclonal) 
BioLegend 504111 (1:200) 
antibody 
anti-mouse IFN-
(rat monoclonal) 
BioLegend 505810 (1:200) 
antibody 
PBS57-loaded CD1d-
tetramer (human) 
NIH Tetramer 
Core Facility 
https://tetramer.yerkes.emo
ry.edu 
(1:500) 
antibody 
anti-human CD3 
(mouse monoclonal) 
BioLegend 300418 (1:200) 
antibody 
anti-human CD4 
(rat monoclonal) 
BioLegend 357415 (1:200) 
antibody 
anti-human CD8a 
(mouse monoclonal) 
BioLegend 300913 (1:200) 
antibody 
anti-human CD25 
(mouse monoclonal) 
BioLegend 302613 (1:200) 
antibody 
anti-human CD69 
(mouse monoclonal) 
BioLegend 310921 (1:200) 
antibody 
anti-human V24 
(mouse monoclonal) 
BioLegend 360003 (1:200) 
antibody 
anti-human V11 
(human monoclonal) 
Miltenyi 
Biotech 
130-108-799 (1:200) 
antibody 
anti-human CD19 
(mouse monoclonal) 
BioLegend 302223 (1:200) 
antibody 
anti-human CD14 
(mouse monoclonal) 
BioLegend 325615 (1:200) 
commercial assay or kit 
Zombie  
(fixable viability dye) 
BioLegend 423105 
 
commercial assay or kit 
Dynabeads Biotin 
binder 
Invitrogen 11047 
 
commercial assay or kit 
Click-iT Plus EdU Flow-
cytometry assay kit 
Invitrogen C10418 
 
chemical compound, 
drug 
GalCer (α-
Galactosylceramide, 
KRN7000) 
Enzo Life 
Sciences 
ALX-306-027 
 
chemical compound, 
drug 
OCH 
Enzo Life 
Sciences 
ALX-306-029 
 
software, algorithm MiXCR 
Bolotin et al., 
2013 
https://mixcr.readthedocs.io
/en/master/  
software, algorithm Weblogo 
Crooks et al., 
2004 
https://weblogo.berkeley.ed
u   
software, algorithm Brepertoire 
Margreitter et 
al., 2018 
http://mabra.biomed.kcl.ac.
uk/BRepertoire_5/?  
 496 
 497 
 498 
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Mice  499 
CD1d-KO (on C57BL/6 background), WT C57BL/6, congenic CD45.1 WT C57BL/6 and 500 
Nur77GFP mice were bred under specific pathogen-free (SPF) conditions at the Francis Crick 501 
Institute. Nur77GFP mice were provided by Adrian Hayday (Francis Crick Institute). Rag2GFP 502 
mice were bred at the University of Birmingham. Tissues from germ-free mice were obtained 503 
from the Welcome Trust Sanger Institute (Cambridge, UK). All animal experiments were 504 
approved by the Francis Crick Institute and the King’s College London’s Animal Welfare and 505 
Ethical Review Body and the United Kingdom Home Office.  506 
 507 
Human tissues 508 
Human tissues used in this study were collected with ethical approval from UK Research 509 
Ethics Committees administered through the Integrated Research Application System. All 510 
samples were collected with informed consent. Mononuclear cells from peripheral blood and 511 
tonsils were isolated as previously described (Zhao et al., 2018) and cryopreserved before 512 
use. 513 
 514 
Murine tissue preparation  515 
Spleen, thymus and liver were harvested and smashed through a 45-m strainer to obtain 516 
single-cell suspensions before staining for flow-cytometry. LNs and lung were harvested and 517 
briefly digested (15 min at 37°C) with collagenase (1.5 mg/ml), DNAse (100 g/ml) and 518 
NADase (6mg/ml) before filtering through a 45-m strainer. SI-LP was processed as 519 
described (Saez de Guinoa et al., 2017). Briefly, small intestine (excluding Peyer’s patches) 520 
was flushed with cold PBS, opened longitudinally and incubated for 20 min at 37°C in HBSS 521 
1 mM EDTA, 5% FCS. The supernatant containing epithelial cells and intraepithelial 522 
lymphocytes was discarded and the remaining tissue was incubated for 45 min at 37°C with 523 
collagenase and DNAse as above and filtered through 45-m strainer. Cells from all the 524 
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tissues were resuspended in FACS buffer (PBS 1% BSA, 1% FCS) for flow-cytometry 525 
staining. 526 
 527 
Flow-cytometry 528 
Flow cytometry staining of mouse and human samples were performed in FACS buffer using 529 
the following antibodies from Biolegend or eBioscience unless specified otherwise: Anti-530 
mouse antibodies: CD45R/B220 (RA 3-6B2), CD8 (56-6.7), CD11b (M1/70), CD11c 531 
(N418), PLZF (9E12), RORt (Q31-378 BD Biosciences), T-bet (4B10), TCR (H57-587), 532 
V7 (TR310), V8.1/8.2 (KJ16), PD-1 (29F.1A12), CCR7 (4B12), Qa2 (1-1-2, BD 533 
Biosciences), CD25 (PC-61), Ki-67 (16A8), CD45.1 (A20), CD45.2 (104), ICOS (7E.17G9), 534 
CD4 (GK1.5), NK1.1 (PK136), CD27 (LG.3A10), CCR6 (29-2L17), CCR8 (SA214G2), IL-4 535 
(11B11), IFN- (XMG1.2). Anti-human antibodies: CD3 (HIT3a), CD4 (A161A1), CD8 536 
(HIT8a), CD25 (BC96), CD69 (FN50), V24 (C15/TCR V24), V11 (REA559, Miltenyi 537 
Biotech), CD19 (HIB19), CD14 (HCD14). PBS57-loaded mouse and human CD1d tetramers 538 
were provided by the NIH Tetramer Core Facility. Incubations were performed on ice except 539 
for CCR7 staining in which cells were incubated with antibodies for 45 min at 37 oC. For 540 
transcription factor staining, cells were fixed and permeabilised with Foxp3/Transcription 541 
Factor Staining Buffer Set (eBioscience). For intracellular cytokine staining, cells were fixed 542 
and permeabilised with Fixation/Permeabilization Solution Kit (BD Biosciences). Dead cells 543 
were detected with Zombie fixable viability kit (Biolegend). Flow-cytometry data were 544 
collected on a Fortessa or Fortessa X20 flow cytometers (both from BD Biosciences) and 545 
were analysed with FlowJo software (TreeStar). 546 
 547 
Administration of antibiotics and EdU incorporation  548 
Mice were orally administrated a cocktail of antibiotics: 1 mg/ml Ampicillin, 1 mg/ml 549 
Gentamicin, 1 mg/ml Neomycin, 1 mg/ml Metronidazole and 0.5 mg/ml Vancomycin (all from 550 
Sigma-Aldrich) in filtered drinking water for 6 weeks (Jimeno et al., 2018).  551 
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For EdU incorporation experiments mice were injected intraperitoneally with 500 g of EdU 552 
for 2 consecutive days and EdU incorporation was detected with Click-iT Plus EdU Flow-553 
cytometry assay kit (Life Technologies). 554 
 555 
Lipids and tetramer loading 556 
CD1d tetramers were provided by the NIH Tetramer Core Facility. GalCer and OCH were 557 
obtained from Enzo Life sciences. ßGalactosylCeramide (C12; βGalCer) was from Avanti 558 
Polar Lipids. αGlucosylCeramide (C26; αGlcCer) and ßGlucosylCeramide (C14; βGlcCer) 559 
were produced in house (University of Birmingham). Lipids were dissolved in 0.5% v/v 560 
Tyloxapol (Sigma) and loaded into CD1d at a three to six-fold molar excess. 561 
 562 
Stimulation with lipid antigens and adoptive transfer 563 
For in vivo experiments mice were injected intravenously with 5 g of OCH or 1 g of 564 
GalCer and sacrificed at the indicated time-points. 565 
For in vitro stimulation experiments, single cell suspensions from the spleen where prepared 566 
as described above. Cells were cultured in complete media (IMDM, 10% FCS) and 567 
stimulated for 2.5 h in the presence of 5g/mL GalCer at 37oC. Brefeldin A (Biolegend) was 568 
added for the last 2 h of the incubation period. Cells were stained for detection of 569 
intracellular cytokines as described above. 570 
For adoptive transfer experiments, donor mice were injected with anti-ARTC2 nanobody 571 
(Treg-protector, Biolegend) 15 min before tissue harvesting. Single-cell suspension from 572 
spleen and thymus were prepared and red blood cells were lysed by incubation with lysis 573 
buffer. Next, cells were incubated with biotinylated anti-B220 antibody followed by 574 
Dynabeads biotin binder magnetic beads (Invitrogen) according to the manufacturer’s 575 
instructions. Cells were resuspended in PBS and injected intravenously into congenic 576 
recipient mice. Tissues were harvested for analyses 12 days after transfer. 577 
 578 
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RNA sequencing 579 
RNA was extracted from sort-purified iNKT cells (TCR+CD1d-tet-PBS57+B220-CD11b-580 
CD11c-CD8-) from the indicated tissues of WT mice using the RNAeasy micro kit (Qiagen) 581 
following manufacturer instructions. Library generation was performed according to 582 
manufacturer instructions using the Nugen Ovation ultralow kit. Libraries were barcoded and 583 
run on an Illumina HiSeq 2500 system with paired-end read lengths of 101 bp. Fastq files 584 
were trimmed using Cutadapt with a quality threshold of 10 before being aligned to and 585 
quantified against release GRCm38.p6 of the mouse genome with RSEM/Bowtie2. The raw 586 
counts were then imported into R/Bioconductor. DESeq2 was used to account for the 587 
different size factors between samples, and a model with main effects of tissue and sample-588 
batch was used to find genes that were differentially expressed (false discovery threshold of 589 
0.01) either between pairs of tissues (Wald test) or not constant across all tissues (likelihood 590 
ratio test). The RNAseq data are available in the Gene Expression Omnibus (GEO) 591 
database with accession number GSE131420 592 
 593 
Analyses of TCR sequences 594 
MiXCR software was used to identify TCR sequences within the RNAseq data (Bolotin et al., 595 
2013). The software performs CDR3 extraction, identifies V, D and J segments, assembles 596 
clonotypes, filters out or rescues low-quality reads. The obtained repertoires were further 597 
filtered to eliminate out-of-frame and stop codon-containing CDR3 variants. CDR3 length, 598 
CDR3 physicochemical properties (hydrophobicity (based on the Kyte–Doolittle scale (Kyte 599 
& Doolittle, 1982)), isoelectric point (pI, according to EMBOSS (Rice et al., 2000)), frequency 600 
of polar (D, E, H, K, N, Q, R, S, T), aliphatic (A, I, L, V) or aromatic (F, H, W, Y) residues), 601 
CDR3 clonal size and V-J pairings were calculated using Brepertoire (Margreitter et al., 602 
2018). CDR3 and CDR3 sequence logos were generated on the Weblogo server (Crooks 603 
et al., 2004) (https://weblogo.berkeley.edu) and provide a visual representation of amino 604 
acids enriched at different positions in the CDR3 sequences. 605 
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 606 
Statistical analyses 607 
Statistical analyses were performed using Prism software (GraphPad). Unless specified 608 
otherwise, n represents the number of individual mice analysed in each experiment. 609 
Statistical significance was determined using paired or unpaired two-tailed student’s t test or 610 
ANOVA with multiple comparison Tukey test as specified in the figure legends. Correlation 611 
analyses were performed using Pearson correlation.  612 
 613 
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FIGURE LEGENDS 628 
Figure 1. Different TCRV usage and clonal expansion in iNKT cells from several 629 
lymphoid tissues  630 
(A) Flow cytometry plots showing gating strategy (left) and quantification (right) for iNKT 631 
cells expressing V7, V8.1/8.2 or Vother (non-V7 or V8.1/8.2) in the depicted tissues of 632 
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WT C57BL/6. Bars represent mean +/- SEM. *p< 0.05, **p< 0.01, *** p< 0.001, ****p<0.0001 633 
paired t-test. n = 15 mice from 5 independent experiments. 634 
(B) Frequency of TRBV gene usage in iNKT cell TCR sequences. Frequencies are 635 
calculated from RNAseq data from 4 samples per tissue. Bars represent mean +/- SEM. *p< 636 
0.05, ***p< 0.001, ****p< 0.0001, ANOVA with Tukey’s multiple comparison test.  637 
(C) Gene usage plot (2D) showing TRAV-TRAJ (top) and TRBV-TRBJ (bottom) pairing for 638 
total TCR sequences obtained from iNKT cells isolated from the depicted tissues of WT 639 
mice. The circle size represents the percentage of sequences with each specific V-J pairing 640 
from the total TCR sequences for each tissue.  641 
(D) Visual representation for aa enrichment at each position for CDR3 (top) and CDR3 642 
(bottom) sequences for iNKT cells (pooled from all tissues). Analyses were performed with 643 
sequences of 15 or 14 aa for CDR3and CDR3 respectively. Graphics were generated 644 
with Weblogo. 645 
(E) Median value for counts for CDR3 sequences identified in the depicted tissues. Data 646 
obtained from RNAseq and pooled from 4 samples per tissue. Data have been calculated 647 
using the counts for each CDR3 sequence and expressed as box-and-whisker diagrams 648 
depicting the median +/- lower quartile, upper quartile, sample minimum and maximum. 649 
****p<0.0001 Mann-Whitney test.  650 
(F) Frequency of CDR3 clonotype usage in relation to the repertoire size for iNKT cells 651 
isolated from the depicted tissues (data obtained from RNAseq and pooled from 4 samples 652 
per tissue).  Frequency of CDR3 sequences present once, twice, 3, 4 or 5 or more times 653 
are shown. 654 
(G) Cumulative frequencies occupied by the 25 most prevalent CDR3 clonotypes for iNKT 655 
cells isolated from the depicted tissues. Data has been calculated for sequences from 4 656 
samples per tissue and represented as mean +/- SEM. *p<0.05, paired t-test.  657 
 658 
Figure 2. Distinct TCRV usage for iNKT RTE  659 
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(A-B) iNKT RTE were identified as GFP+ cells in the tissues of RAG2GFP mice (6-9 660 
weeks/old). (A) Flow-cytometry (left) and quantification (right) showing the percentage of 661 
RAG2GFP+ iNKT cells and the MFI for the GFP expression in RTE in the depicted tissues.  662 
(B) Frequency of V7 or V8.1/8.2-expressing GFP+ and GFP- iNKT cells from the tissues of 663 
RAG2GFP mice.  664 
Bars represent mean +/- SEM. *p< 0.05, **p< 0.01, ****p<0.0001 two-tailed unpaired (A) or 665 
paired t-test (B). n= 6 mice from 2 independent experiments. 666 
 667 
Figure 3. Increased activation and proliferation of LN iNKT cells 668 
(A) Plots show differentially expressed genes for pairwise comparisons from iNKT cells from 669 
the depicted tissues. A fold change cut-off of 1.5 and adjusted p-value cut off of 0.01 were 670 
applied to colour code differentially expressed genes on the plot (red). The numbers of 671 
differentially expressed genes are indicated in the graphs. 672 
(B) Heat map showing RNAseq analyses of selected transcripts significantly changed in 673 
iNKT cells from thymus, mLN or iLN versus spleen. n=4 samples. 674 
(C) Top, Representative flow-cytometry histograms showing GFP expression in iNKT cells 675 
(grey) and T cells (blue) from the depicted tissues of Nur77GFP mice. iNKT cells from the 676 
tissues of Nur77GFP- mice are shown as control (empty profile). Bottom, representative flow-677 
cytometry plots showing CD25, ICOS and CCR8 expression in iNKT cells from the tissues of 678 
WT mice (grey) and control (blue). 679 
(D-E) Ki-67 expression in iNKT cells and T cells from the depicted tissues of WT mice. Ki-67 680 
MFI for iNKT cells (E) is related to T cells from each tissue. Bars represent mean +/- SEM. 681 
*p< 0.05, **p< 0.01, two-tailed unpaired t-test. n=5 mice from 2 independent experiments. 682 
(F) Quantification of EdU incorporation for iNKT cells from the depicted tissues after 48h of 683 
EdU administration in vivo. Bars represent mean +/- SEM. **p< 0.01, ****p<0.0001 two-tailed 684 
unpaired t-test. n=6 mice from 3 independent experiments. 685 
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(G) Representative flow-cytometry plot showing EdU incorporation in iNKT cells (left) and 686 
frequency of V7 or V8.1/8.2-expressing EdU+ and EdU- iNKT cells (right). n=4 mice 687 
(H) Heat map representation of the frequency of TRBV amongst low-abundance (1 copy) or 688 
more abundant (>2 copies) CDR3 sequences obtained from iLN and mLN as indicated. 689 
Data obtained from RNAseq and pooled from 4 samples per tissue. 690 
 691 
Figure 4. The tissue of origin dictates the basal activation and TCR repertoire of all 692 
iNKT subsets 693 
(A) Analysis of iNKT cell populations in the tissues of WT C57BL/6 mice, showing flow-694 
cytometry plots (A, left) and frequency (A, right) of NKT1 (RORt-PLZFloT-bet+), NKT2 695 
(RORt-PLZFhiT-bet-) and NKT17 (PLZFintRORt+) cells. n=10 mice from 4 independent 696 
experiments 697 
(B) Top, Representative flow-cytometry plots showing Ki-67, CD25 and ICOS expression in 698 
NKT1, NKT2 and NKT17 cells from the depicted tissues. Subpopulations were identified as 699 
in (A). Bottom, GFP expression in iNKT cell subsets from the depicted tissues from Nur77GFP 700 
mice. iNKT cell subsets were identified as described (Engel et al., 2016): NKT1 701 
(CD27+NK1.1+), NKT2 (CD27+, NK1.1-, CD1d-Tethi, CD4+), NKT17 (CD27-, CD4-, CCR6+). 702 
(C) Frequency of V7- or V8.1/8.2-expressing iNKT cells within the NKT1 (top), NKT2 703 
(middle) or NKT17 (bottom) populations in the depicted tissues of WT mice. n=10 mice from 704 
4 independent experiments. Bars represent mean +/- SEM. *p< 0.05, **p< 0.01, ***p< 0.001, 705 
****p<0.0001 paired t-test  706 
 707 
Figure 5. Differential lipid antigen recognition for iNKT cells from various lymphoid 708 
tissues 709 
(A-D) iNKT cells from the depicted tissues were co-stained with CD1d-tet-PBS57 and CD1d-710 
tet-GlcCer or CD1d-tet-OCH. (A) Flow-cytometry profiles. (B) Quantification of GlcCer- 711 
(left) or OCH- (right) iNKT cells. Bars represent mean +/- SEM. *p< 0.05, **p< 0.01, ***p< 712 
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0.001, two-tailed paired t-test. (C) V usage for the depicted iNKT cell populations from the 713 
spleen. (D) Frequency of GlcCer+ (left) or OCH+ (right) iNKT cells was related to the 714 
frequency of V8.1/8.2 usage for each sample. Pearson correlation analyses are shown for 715 
each graph. n=6-8 mice from 3-4 independent experiments. 716 
(E-F) TCR V repertoire and lipid antigen recognition of iNKT cells from the depicted tissues 717 
were analysed at indicated time points (weeks of age). (E) Frequency of iNKT cells 718 
expressing V7, V8.1/8.2 or Vother (no V7 or V8.1/8.2) in the tissues of WT C57BL/6 719 
mice of 2, 6 or 11 weeks of age. n= 10-15 mice from 10 independent experiments. (F) Flow-720 
cytometry profiles (left) and quantification of GlcCer- iNKT cells (right) for iNKT cells from 721 
the tissues of WT mice of 2 or 11 weeks of age as depicted. n=3 mice from 2 independent 722 
experiments. Bars represent mean +/- SEM. *p< 0.05, **p< 0.01, ***p< 0.001, ****p<0.0001 723 
two-tailed unpaired t-test. 724 
 725 
Figure 6. TCR repertoire of iNKT cells changes following immunisation and 726 
environmental challenges 727 
(A-D) Mice were injected with OCH (or PBS as control, c) and iNKT cells from spleen and 728 
lymph nodes were analysed 3 or 13 days later. (A) Flow-cytometry profiles showing Ki-67 729 
expression in all iNKT cells (left) and V7, V8.1/8.2 expression for iNKT cells expressing 730 
high (Ki-67hi, right) or low (Ki-67lo, middle) Ki-67 3 days after OCH administration. (B-D) Bar 731 
plots showing expression of Ki-67 (B), frequency of iNKT cells (C) and percentage of iNKT 732 
cells expressing V7 or V8.1/8.2 (D) at the depicted time points in spleen (yellow), mLN 733 
(blue) or iLN (red). n=3-5 mice from 2-3 independent experiments. 734 
(E-F) Frequency of iNKT cells expressing V7 or V8.1/8.2 in the tissues of mice (Thymus= 735 
grey; Spleen= yellow; mLN= blue; iLN= red) treated with antibiotics in the drinking water vs 736 
control mice (E) or SPF vs GF mice (F). n=10 mice (E) and n=6 mice (F) from 2 independent 737 
experiments. 738 
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(A-F) Bars represent mean +/- SEM. *p< 0.05, **p< 0.01, *** p< 0.001, ****p<0.0001 two-739 
tailed unpaired t-test. 740 
 741 
Figure 7. Distinct phenotype and TCR repertoire for human iNKT cells from different 742 
anatomical locations.  743 
(A) Mean percentage of iNKT cells (CD1d-tet-PBS57+CD3+) from total CD3+B220-CD14- 744 
cells in blood or tonsils.  745 
(B-C) Flow-cytometry (left) and quantification (right) showing the percentage of CD4+, CD8+ 746 
and DN cells (B) or CD69+ and CD25+ cells (C) within the iNKT cell population in the 747 
depicted tissues. 748 
 (D-E) Flow-cytometry (left) and quantification (right) showing the percentage of V11- iNKT 749 
cells within CD1d-tet-PBS57+Vα24+ cells (D); or the percentage of Vα24- cells within CD1d-750 
tet-PBS57+V11+ cells (E) 751 
(A-E) Data are expressed as box-and-whisker diagrams depicting the median +/- lower 752 
quartile, upper quartile, sample minimum and maximum. *p< 0.05, *** p< 0.001, two-tailed 753 
unpaired t-test. n=10 samples per tissue from 4 independent experiments. 754 
 755 
 756 
SUPPLEMENTARY FIGURE LEGENDS 757 
Figure 1 - figure supplement 1. Tissue-dependent bias for TCRV usage in iNKT cells 758 
(A) Flow cytometry profiles showing iNKT cells (TCR+CD1d-tet-PBS57+) in the depicted 759 
tissues of WT and CD1d-KO mice. Numbers indicate percentage of iNKT cells within TCR+ 760 
cells. (B) Quantification of iNKT cells expressing V7, V8.1/8.2 or Vother (non-V7 or 761 
V8.1/8.2) in the depicted tissues of WT C57BL/6 mice. Bars represent mean +/- SEM. *p< 762 
0.05, **p< 0.01, *** p< 0.001 two-tailed unpaired t-test. n = 7 mice from 3 independent 763 
experiments. (C) iNKT cells enriched from spleen and thymus were adoptively transferred 764 
into congenic mice and TCRV usage in iNKT cells homing to various tissues was analysed 765 
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12 days later. Flow-cytometry plots show expression of V7 and V8.1/8.2 in iNKT cells from 766 
donor (CD45.2+) and recipient (CD45.1+CD45.2+) mice before or 12 days after transfer. Bar 767 
plots show frequency of donor and recipient iNKT cells expressing V7 or V8.1/8.2 in the 768 
depicted tissues. Bars represent mean +/- SEM. n=5 recipient mice from 2 independent 769 
experiments. *p< 0.05, **p< 0.01, *** p< 0.001 two-tailed unpaired t-test 770 
 771 
Figure 1 - figure supplement 2. Frequency of TRBV and TRAV gene usage in iNKT cell 772 
TCR sequences. (A) Total number of TRAV and TRBV sequences and percentages of 773 
unique sequences obtained from cells on the indicated tissues. (B) Heat map representation 774 
of the frequency of TRAV, TRAJ, TRBV and TRBJ sequences for iNKT cells isolated from 775 
the depicted tissues. Data obtained from RNAseq and pooled from 4 samples per tissue. 776 
 777 
Figure 1 - figure supplement 3. Physicochemical properties of CDR3 sequences. 778 
Median values for length, hydrophobicity, pl, and frequency of polar, aromatic or aliphatic aa 779 
in CDR3 sequences identified in the depicted tissues. Data are expressed as box-and-780 
whisker diagrams depicting the median +/- lower quartile, upper quartile, sample minimum 781 
and maximum. Data obtained from RNAseq and pooled from 4 samples per tissue. 782 
 783 
Figure 2 - figure supplement 1. TCRV usage for iNKT cell precursors. (A) iNKT cell 784 
precursors were identified by flow-cytometry (left top) as CCR7+PD-1- cells. Q2a expression 785 
in iNKT cell precursors (empty profile) and non-precursors (grey, rest) is shown (left bottom). 786 
Bar plot shows quantification of CCR7+PD-1- iNKT cells in the depicted tissues (right). ****p< 787 
0.0001, two-tailed unpaired paired t-test. n= 5 mice from 3 independent experiments. (B) 788 
Flow-cytometry plots showing expression of CCR7, PD1, Qa2 and GFP in iNKT cells from 789 
Rag2-GFP mice. (C) Frequency of V7 or V8.1/8.2-expressing iNKT cell precursors 790 
(CCR7+PD-1- ) and non-precursors (rest) from the tissues of WT mice. *p< 0.05, **p< 0.01, 791 
two-tailed paired t-test. n= 5 mice from 3 independent experiments. 792 
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 793 
Figure 3 - figure supplement 1. Gene expression analyses for iNKT cells from various 794 
tissues. (A) Differentially expressed genes upregulated (red) or downregulated (blue) in 795 
iNKT cells from LNs vs. iNKT cells from spleen/thymus. A fold change cut-off of 1.5 and 796 
adjusted p-value cut off of 0.01 were applied to colour code differentially expressed genes 797 
on the plot. (B) Functional enrichment analysis of genes upregulated in LN iNKT cells (vs 798 
spleen/thymus iNKT; top) or in spleen/thymus iNKT cells (vs LN iNKT; bottom). The GO 799 
terms are shown for both sets of genes ranked by p values and fold-enrichments are 800 
depicted on the graph. Enrichment and p values (from a Fisher’s exact test with Bonferroni 801 
correction) were calculated with PANTHER tools. (C) Frequency of V7 or V8.1/8.2-802 
expressing EdU+ or EdU- iNKT cells from mLN (blue) or iLN (red). n=4 mice from 2 803 
experiments. *p< 0.05, two-tailed paired t-test. 804 
 805 
Figure 4 - figure supplement 1. TCRV usage for iNKT cell subpopulations. (Top) 806 
Analysis of iNKT cell populations in the tissues of WT C57BL/6 mice, showing flow-807 
cytometry plots (left) and frequency (right) of CD4+NK1.1-, NK1.1+CD4-, CD4+NK1.1+ or CD4-808 
NK1.1- iNKT cells. (Bottom) Frequency of V7- or V8.1/8.2-expressing iNKT cells within the 809 
CD4+NK1.1-, NK1.1+CD4-, CD4+NK1.1+ or CD4-NK1.1- populations in the depicted tissues of 810 
WT mice. n=5 mice from 2 independent experiments. Bars represent mean +/- SEM. *p< 811 
0.05, **p< 0.01, ***p< 0.001, ****p<0.0001, ANOVA with Tukey’s multiple comparisons test. 812 
 813 
Figure 5 - figure supplement 1. Differential lipid antigen recognition for iNKT cells 814 
from non-lymphoid tissues (A-D) iNKT cells from liver, lung or SI-LP were co-stained with 815 
CD1d-tet-PBS57 and CD1d-tet-GlcCer or CD1d-tet-OCH. (A) Flow-cytometry profiles. (B) 816 
Quantification of GlcCer- (left) or OCH- (right) iNKT cells. Bars represent mean +/- SEM. 817 
*p< 0.05, **p< 0.01, ***p< 0.001, two-tailed paired t-test. n=4 mice from 2 independent 818 
experiments. (C) V usage for the depicted iNKT cell populations from the liver. (D) 819 
 34 
Frequency of GlcCer+ (left) or OCH+ (right) iNKT cells was related to the frequency of 820 
V8.1/8.2 usage for each sample. Pearson correlation analyses are shown for each graph.  821 
 822 
Figure 6 - figure supplement 1. Changes in the iNKT cell TCR repertoire following 823 
immunisation with GalCer. Mice were injected with GalCer (or PBS as control) and 824 
iNKT cells from spleen and lymph nodes were analysed 3 days later. (A) Flow-cytometry 825 
profiles showing Ki-67 expression in all iNKT cells (left) and V7, V8.1/8.2 expression for 826 
iNKT cells expressing high (Ki-67hi, right) or low (Ki-67lo, middle) Ki-67 3 days after GalCer 827 
administration. (B-D) Bar plots showing expression of Ki-67 (B), frequency of iNKT cells (C) 828 
and percentage of iNKT cells expressing V7, V8.1/8.2 or Vother (D) at the depicted time 829 
points in spleen (yellow), mLN (blue) or iLN (red). n=3 mice from 2 independent 830 
experiments. Bars represent mean +/- SEM. *p< 0.05, **p< 0.01, *** p< 0.001, ****p<0.0001 831 
two-tailed unpaired t-test. 832 
 833 
Figure 6 - figure supplement 2. Cytokine secretion by iNKT cells relates to 834 
TCRVusage. Splenocytes were stimulated in vitro with GalCer (left, in vitro) or WT mice 835 
were injected in vivo with GalCer (right, in vivo) and cytokine production was measured by 836 
intracellular staining 2h later. Flow cytometry graphs and quantification (bar plots) showing 837 
the frequency of IL-4 or IFN--producing iNKT cells within the V7+, V8+ or Vother+ 838 
populations.  n=7 mice (in vitro) and n=4 mice (in vivo). Bars represent mean +/- SEM. *p< 839 
0.05, **p< 0.01, ***p< 0.001, ANOVA with Tukey’s multiple comparisons test. 840 
 841 
 842 
Figure 6 - figure supplement 3. Frequency of iNKT cells after antibiotic treatment. 843 
Frequency of iNKT cells in the tissues of mice (Thymus= grey; Spleen= yellow; mLN= blue; 844 
iLN= red) treated with antibiotics in the drinking water vs control mice. n=10 mice from 2 845 
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independent experiments. Bars represent mean +/- SEM. **p< 0.01 two-tailed unpaired t-846 
test. 847 
 848 
SOURCE DATA FILES 849 
Figure 1- source data 1. Different TCRV usage and clonal expansion in iNKT cells from 850 
several lymphoid tissues 851 
Figure 2- source data 1. Distinct TCRV usage for iNKT RTE 852 
Figure 3- source data 1. Increased activation and proliferation of LN iNKT cells 853 
Figure 4- source data 1. The tissue of origin dictates the basal activation and TCR 854 
repertoire of all iNKT subsets  855 
Figure 5- source data 1. Differential lipid antigen recognition for iNKT cells from various 856 
lymphoid tissues 857 
Figure 6- source data 1. TCR repertoire of iNKT cells changes following immunisation and 858 
environmental challenges 859 
Figure 7- source data 1. Distinct phenotype and TCR repertoire for human iNKT cells from 860 
different anatomical locations.  861 
 862 
Figure 1 - figure supplement 1- source data 1. Tissue-dependent bias for TCRV usage 863 
in iNKT cells  864 
Figure 1 - figure supplement 2- source data 1. Frequency of TRBV and TRAV gene 865 
usage in iNKT cell TCR sequences. 866 
Figure 1 - figure supplement 3- source data 1. Physicochemical properties of CDR3 867 
sequences. 868 
Figure 2 - figure supplement 1- source data 1. TCRV usage for iNKT cell precursors 869 
Figure 3 - figure supplement 1- source data 1. Gene expression analyses for iNKT cells 870 
from various tissues. 871 
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Figure 4 - figure supplement 1- source data 1. TCRV usage for iNKT cell 872 
subpopulations. 873 
Figure 5 - figure supplement 1- source data 1. Differential lipid antigen recognition for 874 
iNKT cells from non-lymphoid tissues 875 
Figure 6 - figure supplement 1- source data 1. Changes in the iNKT cell TCR repertoire 876 
following immunisation with GalCer  877 
Figure 6 - figure supplement 2- source data 1. Cytokine secretion by iNKT cells relates to 878 
TCRVusage. 879 
Figure 6 - figure supplement 3- source data 1. Frequency of iNKT cells after antibiotic 880 
treatment. 881 
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